Wednesday, June 29, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Integrating Microplate Evaporators with Liquid Handling Robots

by Medical Finance
in News
Integrating Microplate Evaporators with Liquid Handling Robots
9
SHARES
105
VIEWS
Share on FacebookShare on Twitter

The Ultravap® Mistral family of microplate evaporators from Porvair Sciences are used in labs worldwide to remove the traditional laboratory ‘bottleneck’ of solvent evaporation from 12- to 384-well microplates and vials up to 15cm tall.

PorvairPR583 image

Image credit: Porvair Sciences

The latest generation of Ultravap® Mistral evaporators are designed with new flat front profile and platform shuttle enabling easy interfacing with liquid-handling robots for increased automation efficiency. Reproducible sample throughput is achieved by proprietary advances in gas injection technology to directly and consistently deliver heated gas in each well and tube. It is however the full RS232 control of every parameter achieved through powerful operating software combined with its open-access design – that enables the Ultravap® Mistral to be easily integrated with liquid handling robots to gain the full benefit of automating microplate dry-down.

The Ultravap® Mistral XT-150 is Porvair’s most advanced evaporator yet, giving significant throughput advantages to laboratories routinely tasked with sample preparation. Faster than centrifugal evaporation for single plates and tube racks, significant increases in sample throughput are achieved through advanced evaporator head technology and an innovative manifold design, which directly injects heated nitrogen (temperatures up to 80C) into each individual well of the microplate simultaneously.

The Ultravap® Mistral core software has been specially coded to allow simultaneous control of multiple operating units from a single, primary Ultravap® Mistral evaporator. Using the latest CAN interface technology, Ultravap® Mistral units can be connected together in series. A method selected on a primary unit will be automatically distributed over the CAN Bus to all downstream units to run the programme simultaneously.

For further information on fully automating your microplate dry down protocols please visit https://www.microplates.com/blowdown-evaporator-ultravap-mistral/ or contact Porvair Sciences at  [email protected] or call +44 1978 666222 / +1 800 552 3696.

Porvair Sciences, together with JG Finneran and Porvair Kbiosytems are global manufacturers of consumables and instruments for life science and analytical workflows. From microplate technologies, glass vials, assay kits to automated laboratory equipment, the group is committed to equipping customers with high quality products for improved analysis and increased productivity to accelerate scientific discovery with integrity.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Memory B cells can be localized in the lungs, research shows

by Medical Finance
June 29, 2022
0

How can we increase the efficacy of vaccines used to protect against viral respiratory diseases such as influenza and COVID-19?...

Bacterial biofilms use a developmental patterning mechanism seen in plants and animals

UMass Amherst assistant professor wins $1.4 million grant to engineer synthetic bacteria for water contaminant removal

by Medical Finance
June 29, 2022
0

Lauren Andrews, University of Massachusetts Amherst assistant professor and the Marvin and Eva Schlanger Faculty Fellow in the department of...

Why millions on Medicaid are at risk of losing coverage in the months ahead

Duke researchers identify role for key gene in developmental disability syndrome

by Medical Finance
June 29, 2022
0

A single gene that was previously found to be the driving force in a rare syndrome linked to epilepsy, autism...

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Scientists discover how to prevent T cell exhaustion to maintain the fight against cancer

by Medical Finance
June 28, 2022
0

When faced with a formidable foe for months on end, the immune system's T cells begin to tire. Whether fighting...

Cannabinoids may prevent infection with SARS-CoV-2, including variants

Cannabinoids may prevent infection with SARS-CoV-2, including variants

by Medical Finance
June 29, 2022
0

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy...

Monitoring the presence of enteric pathogens in imported seafood

The Native Antigen Company Expands Range of Norovirus-Like Particles

by Medical Finance
June 28, 2022
0

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into...

Next Post
Study: The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters. Image Credit: NIAID

Nitazoxanide shows promise for COVID-19 treatment in animal model

Study: Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice​​​​​​​. Image Credit: ktsdesign / Shutterstock

mRNA-1273 and mRNA-1273.529 Omicron-specific boosters highly effective in mouse model

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Web and social media searches highlight menstrual irregularities as a global concern in COVID-19 vaccinations. Image Credit: 13_Phunkod / Shutterstock.com
    The spread of menstrual irregularity and COVID-19 vaccines concerns on the web
  • 174318220 620x480
    NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply